z-logo
Premium
Primary cutaneous histiocyte and neutrophil‐rich CD30 + and CD56 + anaplastic large‐cell lymphoma with prominent angioinvasion and nerve involvement in the forehead and scalp of an immunocompetent woman
Author(s) -
Boudova Ludmila,
Kazakov Dmitry V.,
Jindra Pavel,
Sima Radek,
Vanecek Tomáš,
Kuntscher Vilem,
Vera Vozobulova,
Bouda Jiri,
Michal Michal
Publication year - 2006
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1111/j.1600-0560.2006.00488.x
Subject(s) - cd30 , pathology , anaplastic large cell lymphoma , medicine , vincristine , histiocyte , lymphoma , prednisone , chemotherapy , cyclophosphamide
Background:  Cutaneous lymphomas co‐expressing CD56 and CD30 are very rare. They share a clinicopathological overlap with natural killer‐ (NK)/T‐cell lymphomas and anaplastic large‐cell lymphomas (ALCLs), two entities with widely disparate clinical behavior. Methods:  We present a case of an immunocompetent 57‐year‐old Caucasian woman with a rapidly growing, angiodestructive and neuroinvasive primary cutaneous ALCL (PCALCL). The neoplastic population of large anaplastic CD30 + and CD56 + T cells was masked by a massive admixture of histiocytes and neutrophils. The partially ulcerated and pus‐secreting tumor involved the forehead and scalp and was assessed as clinical stage IAE. Results:  After chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone), the patient achieved a complete remission. Additionally, high‐dose chemotherapy with autologous peripheral blood stem‐cell transplantation was administered as a consolidation of complete remission, in which she has remained for 6 years. Conclusions:  This is the first CD30 + and CD56 + primary skin lymphoma to be reported on the head. The presented case carries a remarkable combination of clinicopathological features of PCALCL and NK‐/T‐cell lymphoma.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom